Sponsored Links
Lymphoma Information Network » Lymphoma Info » What is Lymphoma?

What is Lymphoma?

Lymphoma is a general term for cancer in the lymph system. The lymph system is made up of many cells and organs, including the lymph nodes, thymus gland, spleen, and liver. This system produces B-Cells and T-Cells, which make up your body’s immune system. Since these cells travel between the lymphatic and circulatory system while fighting infections and viruses, lymphomas are blood-related cancers.

lymph node schematic
Lymph node schematic showing lymph sinuses
 

Types of Lymphomas

There are two main categories of lymphomas: Hodgkin’s lymphoma (aka Hodgkin’s disease or Hodgkin lymphoma) and Non-Hodgkin’s lymphomas (NHL). Hodgkin’s disease is a very specific type of cancer that involves a mutation in Reed-Sternberg cells.

Non-Hodgkin’s Lymphomas involve mutations in the body’s B-Cells and T-Cells. B-Cell Lymphomas account for over 80% of all NHL. T-Cell Lymphomas make up the rest.

Symptoms of Lymphoma

Unfortunately, lymphoma doesn’t have many identifying symptoms; those that exist are also indicators for other, more common diseases. For example, typical symptoms include:

  • swollen lymph nodes in the neck, armpit, or groin; usually painless
  • fever and/or night sweats
  • unexplained weight loss
  • fatigue
  • chest pain
  • loss of appetite is less common symptom of some more aggressive lymphomas of the GI tract

Statistics

According to the Leukemia & Lymphoma Society:

  • About 139,860 people living in the United States will be diagnosed with lymphoma, leukemia, or myeloma in 2009. This accounts for 9.5% of expected cancer diagnoses.
  • 12.2 out of every 100,000 people in the world will be diagnosed with leukemia.
  • 19.5 out of every 100,000 people in the world will be diagnosed with Non-Hodgkin’s Lymphoma.
  • 2.8 out of every 100,000 people in the world will be diagnosed with Hodgkin’s Disease.
  • The mortality rate of leukemia and lymphoma has decreased as the survival rate increased due to improved treatments.

Other common statistics reflect that:

  • Males are typically affected more than females.
  • Hodgkin’s Lymphoma is more common in younger patients than other types of lymphoma.
  • Non-Hodgkin’s Lymphomas are more prevalent in patients over 50.

In summary, lymphoma of any type is a systemic disease. It is treatable with generally high survival rates but the road to diagnosis, prognosis and recovery will take time and patience. We hope that these pages can help you along the way.

Sponsored Links

Cancer Support Groups

SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Dive Deeper

disclaimer

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.

Featured Treatment
searching for treatment

Featured Treatment: Zevalin®

Zevalin® (Ibritumomab tiuxetan) is a form of radioimmunotherapy (a radiolabeled monoclonal antibody) for treatment of patients with relapsed or refractory, low‑grade or follicular B‑cell non‑Hodgkin's lymphoma (NHL). "Refractory" refers to a disease that does not respond to treatment.

Zevalin is the first radioummunotherapy treatment to be FDA-approved as a first-line therapy for lymphoma. Read more...

Sponsored Links
User login
Cancer Support Groups

Cancer Support Groups

support groups

SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Poll
What is most important to you in an Online Support Group?:
Latest Blog Entries
Did You Know?
Since the early 1970s, incidence rates for non-Hodgkin’s lymphoma have nearly doubled. Incidence rates for Hodgkin’s disease have declined about 60%. Better means of diagnosis has also increased the number as doctors better understand cancer of lymphocytes verses other diseases.
lymphomas